Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Drug Discovery Technologies
  4. Fast Track Articles
  5. Fast Track Article
image of Liquisolid Technique for Solubility Enhancement of Poorly Soluble Drug - A Brief Review

Abstract

Most of the newly discovered drug candidates are lipophilic and poorly water-soluble, making it a significant challenge for the pharmaceutical industry to formulate suitable drug delivery systems. This review gives insight into an overview of the liquisolid technique (LST) and summarizes the progress of its various applications in drug delivery. This novel technique involves converting liquid drugs or drugs in a liquid state (such as solutions, suspensions, or emulsions) into dry, non-adherent, free-flowing, and readily compressible powder mixtures by blending or spraying a liquid dispersion onto specific powder carriers and coating materials. In Liquisolid systems, the liquid medication is absorbed into the interior framework of carriers. Once the carrier's interior is saturated with liquid medication, a liquid layer forms on the surface of the carrier particles, which is instantly adsorbed by the fine coating material. As a result, a dry, free-flowing, and compressible powder mixture is formed. Compared to other solubility enhancement techniques, s.a. micronization, inclusion complexation, microencapsulation, nanosuspension, and self-nano emulsions, LST is relatively simple to prepare and may offer a cost-effective solution to enhance the solubility of poorly water-soluble drugs enhancing its bioavailability in drug formulation and delivery.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cddt/10.2174/0115701638318659240923074614
2024-10-04
2024-11-01

  • From This Site

    /content/journals/cddt/10.2174/0115701638318659240923074614
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Prusty A. Formulation And Evaluation of Ciprofloxacin Colon Targeted Tablets By Compression Coating Technique Using Guar Gum and Hydroxy Propyl Methylcellulose. J Res Pharm. 2022 26 6 1593 1607
    [Google Scholar]
  2. Prusty A. Carobomer Based Controlled Release Designs of Atorvastatin Calcium Tablets Evaluated Using Quality by Design (QbD) Approach. American J. Anal. Chem. 2017 8 3 1991862
    [Google Scholar]
  3. Lachman l. The Theory and Practice of Industrial Pharmacy. Special Indian Edition New Delhi CBS Publication & Distributors Pvt. Ltd. 2009 221
    [Google Scholar]
  4. Savkare A.D. Bhavsar M.R. Gholap V.D. Kukkar P.M. Liquisolid technique: A review. Int. J. Pharm. Sci. Res. 2017 8 7 2768 2775
    [Google Scholar]
  5. Geethika G. Compact Technology: A Review. Indo-American J. Pharmaceut. Sci. 2015 2 3 684 691
    [Google Scholar]
  6. Gavali S.M. Liquisolid compact: A New technique for dissolution enhancement. Int. J. Res. Pharm. Chem. 2011 1 3 705 713
    [Google Scholar]
  7. Khaled K.A. Asiri Y.A. El-Sayed Y.M. In vivo evaluation of liquisolid tablets in beagle dogs. Int. J. Pharm. 2001 222 1 6 10.1016/S0378‑5173(01)00633‑0 11404027
    [Google Scholar]
  8. Lu M. Xing H. Jiang J. Chen X. Yang T. Wang D. Ding P. Liquisolid technique and its applications in pharmaceutics. Asian J. Pharmaceut. Sci. 2017 12 2 115 123 10.1016/j.ajps.2016.09.007 32104320
    [Google Scholar]
  9. Hussain Y. Cui J. Dormocara A. Khan H. The most recent advances in liquisolid technology: Perspectives in the pharmaceutical industry. Pharmaceut. Sci. Advances 2024 2 100038 10.1016/j.pscia.2024.100038
    [Google Scholar]
  10. Rashad A. Louis D. An overview on liquisolid technique: Its development and applications. Ther. Deliv. 2022 13 12 577 589 10.4155/tde‑2022‑0057 36861309
    [Google Scholar]
  11. Kesisoglou F. Panmai S. Wu Y. Nanosizing — Oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 2007 59 7 631 644 10.1016/j.addr.2007.05.003 17601629
    [Google Scholar]
  12. Savić R. Eisenberg A. Maysinger D. Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactions. J. Drug Target. 2006 14 6 343 355 10.1080/10611860600874538 17092835
    [Google Scholar]
  13. Ahuja N. Katare O.P. Singh B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur. J. Pharm. Biopharm. 2007 65 1 26 38 10.1016/j.ejpb.2006.07.007 16962750
    [Google Scholar]
  14. Amidon G.L. Lennernäs H. Shah V.P. Crison J.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995 12 3 413 420 10.1023/A:1016212804288 7617530
    [Google Scholar]
  15. Chawdhary K.P.R. Biopharmaceutical classification system. Indian Pharmacist. 2004 2024 7 10
    [Google Scholar]
  16. Jaiswal S.B. Biopharmaceutics and Pharmacokinetics: A Treatise. Delhi, India Vallabh Prakashan 2005
    [Google Scholar]
  17. Aguiar A.J. Deagglomeration Behavior of Relatively Insoluble Benzoic Acid and Its Sodium salt. J. Pharm. Sci. 1967 56 1243 1252 10.1002/jps.2600561006 6059441
    [Google Scholar]
  18. Finholt P. Solvang S. Dissolution kinetics of drugs in human gastric juice--the role of surface tension. J. Pharm. Sci. 1968 57 8 1322 1326 10.1002/jps.2600570809 5677333
    [Google Scholar]
  19. Lin S.L. Menig J. Lachman L. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs. J. Pharm. Sci. 1968 57 12 2143 2148 10.1002/jps.2600571225 5708358
    [Google Scholar]
  20. Spireas S. Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 1998 166 2 177 188 10.1016/S0378‑5173(98)00046‑5
    [Google Scholar]
  21. Spireas S. Sadu S. Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets. J. Pharm. Sci. 1998 87 7 867 872 10.1021/js970346g 9649356
    [Google Scholar]
  22. Spireas S. Effect of Powder Substrate on the Dissolution Properties of Methchrothiazide Liquisolid Compacts. Drug Dev. Ind. Pharm. 1999 25 63 168
    [Google Scholar]
  23. Yang K.Y. Effect of Amorphous Silicon Dioxide on Drug Dissolution. J. Pharm. Sci. 1979 68 560 565 10.1002/jps.2600680511 219197
    [Google Scholar]
  24. Liao C.C. Jarowski C.I. Dissolution rates of corticoid solutions dispersed on silicas. J. Pharm. Sci. 1984 73 3 401 403 10.1002/jps.2600730330 6325660
    [Google Scholar]
  25. Spireas S. Liquisolid systems and methods of preparing same. US Patent 6423339B1 2002
  26. Nokhodchi A. Aliakbar R. Desai S. Javadzadeh Y. Liquisolid compacts: The effect of cosolvent and HPMC on theophylline release. Colloids Surf. B Biointerfaces 2010 79 1 262 269 10.1016/j.colsurfb.2010.04.008 20451361
    [Google Scholar]
  27. Spireas S. Liquisolid systems and methods of preparing same. US Patent 5800834A 1999
  28. Fuji Chemical iNDUSTRIES Co., Ltd. We create safe and useful medicines. 2024 Available From: www.fujichemical.co.jp
  29. Naseem A. Olliff C.J. Martini L.G. Lloyd A.W. Effects of plasma irradiation on the wettability and dissolution of compacts of griseofulvin. Int. J. Pharm. 2004 269 2 443 450 10.1016/j.ijpharm.2003.09.029 14706255
    [Google Scholar]
  30. Gursoy R.N. SelfEmulsifying Drug Delivery Systems (SEDDS) for Improved Oral Delivery of Lipophilic Drug Biomed. Pharmacotherapy 2004 58 173 182 10.1016/j.biopha.2004.02.001
    [Google Scholar]
  31. Kapsi S.G. Ayres J.W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm. 2001 229 1-2 193 203 10.1016/S0378‑5173(01)00867‑5 11604272
    [Google Scholar]
  32. Solvang S. Finholt P. Effect of tablet processing and formulation factors on dissolution rate of the active ingredient in human gastric juice. J. Pharm. Sci. 1970 59 1 49 52 10.1002/jps.2600590106 5411324
    [Google Scholar]
  33. Granero G.E. Ramachandran C. Amidon G.L. Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev. Ind. Pharm. 2005 31 9 917 922 10.1080/03639040500272108 16306004
    [Google Scholar]
  34. Rasenack N. Hartenhauer H. Müller B.W. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 2003 254 2 137 145 10.1016/S0378‑5173(03)00005‑X 12623189
    [Google Scholar]
  35. Javadzadeh Y. Enhancement of Dissolution Rate of Piroxicam Using Liquisolid Compacts. Farmaco 2005 60 361 365
    [Google Scholar]
  36. Nokhodchi A. Javadzadeh Y. Siahi-Shadbad M.R. Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharm. Sci. 2005 8 1 18 25 15946594
    [Google Scholar]
  37. Fahmy R. Kassem M. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2008 69 3 993 1003 10.1016/j.ejpb.2008.02.017 18396390
    [Google Scholar]
  38. Tiong N. Elkordy A.A. Effects of liquisolid formulations on dissolution of naproxen. Eur. J. Pharm. Biopharm. 2009 73 3 373 384 10.1016/j.ejpb.2009.08.002 19679184
    [Google Scholar]
  39. Bolton S. Sustainedrelease Liquisolid Compacts. 25th International Symposium on Controlled Release of Bioactive Materials Nevada USA 1998 138 139
    [Google Scholar]
  40. Yadav V.B. Improvement of Solubility and Dissolution of Indomethacin by Liquisolid and Compaction Granulation Technique. J. Pharm. Sci. 2009 1 2 44 51
    [Google Scholar]
  41. Al-Obaidi H. Nokhodchi A. In vitro release of diltiazem HCl from liquisolid compacts. Drug Dev. Ind. Pharm. 2017 43 6 937 943
    [Google Scholar]
  42. Baertschi S.W Pharmaceutical stress testing: Predicting drug degradation. 2nd ed Boca Raton, Florida CRC Press 2011
    [Google Scholar]
  43. Bozdag S. Ozer Y. Ertan G. The effect of the type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharmacol. 2010 8 1 18 25
    [Google Scholar]
  44. Singh S.K. Srinivasan K.K. Gowthamarajan K. Prakash D. Gaikwad N.B. Singare D.S. Influence of formulation parameters on dissolution rate enhancement of glyburide using liquisolid technique. Drug Dev. Ind. Pharm. 2012 38 8 961 970 10.3109/03639045.2011.634810 22251080
    [Google Scholar]
  45. Farid R.M. Kassem M.A. Elmeshad A.N. Optimization of glibenclamide liquisolid tablets via Box-Behnken design: Influence of formulation variables on dissolution. Eur. J. Pharm. Biopharm. 2010 76 2 207 213 21130874
    [Google Scholar]
  46. Ghosh I. Mukherjee B. Fabrication of lecithin-based liquisolid systems for enhanced solubility and bioavailability of aceclofenac. J. Drug Deliv. Sci. Technol. 2017 39 405 415
    [Google Scholar]
  47. Javadzadeh Y. Musaalrezaei L. Nokhodchi A. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Int. J. Pharm. 2008 362 1-2 102 108 10.1016/j.ijpharm.2008.06.022 18647643
    [Google Scholar]
  48. Kassem M.A. ElMeshad A.N. Liquisolid technique to enhance and sustain griseofulvin dissolution: Effect of choice of non-volatile liquid vehicles. Int. J. Pharm. 2008 361 1-2 85 92
    [Google Scholar]
  49. Saeedi M. Akbari J. Morteza-Semnani K. Enayati-Fard R. Sar-Reshteh-Dar S. Soleymani A. Enhancement of dissolution rate of indomethacin: Using liquisolid compacts. Iran. J. Pharm. Res. 2011 10 1 25 34 24363677
    [Google Scholar]
  50. Liu M.K. Chen H.L. Chen L.L. Jiang H. Liu R. Pei Z.C. Li K. Wei Z.P. Xu H. Andrographolide Liquisolid using Porous-Starch as the Adsorbent with Enhanced Oral Bioavailability in Rats. J. Pharm. Sci. 2023 112 2 535 543 10.1016/j.xphs.2022.08.033 36058257
    [Google Scholar]
  51. Tadros M.I. Fotuzyar S.S. Nokhodchi A. Liquisolid technique as a tool for enhancing the dissolution and bioavailability of furosemide. AAPS PharmSciTech 2010 11 1 355 365
    [Google Scholar]
  52. Ahmed T.A. Alotaibi H.A. Alharbi W.S. Safo M.K. El-Say K.M. Development of 3D-Printed, Liquisolid and Directly Compressed Glimepiride Tablets, Loaded with Black Seed Oil Self-Nanoemulsifying Drug Delivery System: In Vitro and In Vivo Characterization. Pharmaceuticals (Basel) 2022 15 1 68 10.3390/ph15010068 35056126
    [Google Scholar]
  53. Yadav V.B. Enhancement of Solubility and Dissolution Rate of BCS class II Pharmaceuticals by Nonaquious Granulation Technique. Int. J. Pharma Res 2010 12 1 233
    [Google Scholar]
  54. Kapure V.J. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique. J. Pharm. (Cairo) 2013 2017 315902
    [Google Scholar]
  55. Karmarkar A.B. Gonjari I.D. Hosmani A.H. Liquisolid technology for dissolution rate enhancement or sustained release. Expert Opin. Drug Deliv. 2010 7 10 1227 1234 10.1517/17425247.2010.511173 20731614
    [Google Scholar]
  56. Tayel S.A. Improvement of Dissolution Properties of Carbamazepine through Application of the Liquisolid Technique. Eur. J. Pharm. Biopharm. 2008 69 342 347 10.1016/j.ejpb.2007.09.003 17949959
    [Google Scholar]
  57. Yadav V.B. Liquisolid Granulation Technique for Tablet Manufacturing: An Overview J. Pharm. Res. 2009 2 4 670 674
    [Google Scholar]
  58. Akinlade B. Elkordy A.A. Essa E.A. Elhagar S. Liquisolid systems to improve the dissolution of furosemide. Sci. Pharm. 2010 78 2 325 344 10.3797/scipharm.0912‑23 21179350
    [Google Scholar]
  59. Yadav V.B. Tablets. The Theory and Practice of Industrial Pharmacy. Bombay India Varghese Publishing House 1987
    [Google Scholar]
  60. Craig D.Q.M. Reading M. Pharmaceutical applications of DSC. Thermal analysis of pharmaceuticals. Boca Raton, USA CRC Press 2007 53 99
    [Google Scholar]
  61. USP NF The United States Pharmacopoeia National Formulary USP28 NF23 The United States Pharmacopoeial Convention Canada. 2005 Available From: https://archive.org/details/unitedstatesphar00unit
    [Google Scholar]
  62. British Pharmacopoeia The British Pharmacopoeia the Stationary Office London. 2004 Available From: https://www.pharmacopoeia.com/
  63. Sanjeev R.G. Formulation and Characterization of Atorvastatin Calcium Liquisolid Compacts. Asian J. Pharmaceut. Sci. 2010 5 2 50 60
    [Google Scholar]
  64. Surti N. Patel D.S. Pipaliya R.M. Liquisolid tablets for dissolution enhancement of a hypolipidemic drug. Indian J. Pharm. Sci. 2015 77 3 290 298 10.4103/0250‑474X.159618 26180274
    [Google Scholar]
  65. Khaled K.A. Formulation and evaluation of hydrochlorothiazide liquisolid tablets. Saudi Pharm. J. 1988 6 39 46
    [Google Scholar]
  66. Sanjeev G. Liquisolid Technique for Enhancement of Dissolution Properties of Bromhexine Hydrochloride. Saudi Pharm. J. 2009 2 2 83
    [Google Scholar]
  67. Sahil M. Liquisolid Compact: A New Technique for Enhancement of Drug Dissolution. IJRPC 2011 1 3 5558
    [Google Scholar]
  68. Caraballo I. Marasini N. Jiang T. Liquisolid Technology to Improve the Solubility and Dissolution Rate of Loratadine. AAPS PharmSciTech 2018 19 2 707 716 10.1208/s12249‑017‑0934‑0
    [Google Scholar]
  69. Borkar R.M. Jain A.S. Nerkar P.P. Enhancement of dissolution rate of ezetimibe by liquisolid compact technique. Powder Technol. 2014 253 184 193 10.1016/j.powtec.2013.10.056
    [Google Scholar]
  70. Ammar H.O. Ghorab M. Mahmoud A.A. Makram T.S. Rapidly disintegrating tablets containing taste-masked microspheres for eradication of H. pylori: Preparation, in vitro and in vivo evaluation. Int. J. Pharm. 2014 472 1-2 275 283 10.1016/j.ijpharm.2014.06.046 24491528
    [Google Scholar]
  71. Sun D.D. Lee P.I. Probing the in vitro dissolution behavior of highly water-soluble drugs from liquisolid compacts. Eur. J. Pharm. Sci. 2012 47 1 50 60 10.1016/j.ejps.2012.03.004
    [Google Scholar]
  72. Sankalia M.G. Mashru R.C. Sankalia J.M. Sutariya V.B. Stability improvement of aceclofenac liquisolid compact using adsorbents. AAPS PharmSciTech 2007 8 1 E1 E9 10.1208/pt0801001
    [Google Scholar]
  73. Javadzadeh Y. Jafari-Navimipour B. Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int. J. Pharm. 2007 341 1-2 26 34 10.1016/j.ijpharm.2007.03.034 17498898
    [Google Scholar]
  74. Cetin E.M. Yetisgin A.A. Arpag H. Yildiz A. Formulation and in vitro evaluation of carvedilol liquisolid compacts using Aerosil® as a carrier. Int. J. Pharm. Investig. 2018 8 2 88 94 10.4103/jphi.JPHI_30_18
    [Google Scholar]
  75. Singh A. Jain A. Shrivastava S.K. Development and evaluation of liquisolid compacts of glimepiride for improved dissolution. J. Pharm. Bioallied Sci. 2012 4 Suppl. 1 S98 S100 10.4103/0975‑7406.94134
    [Google Scholar]
  76. Hentzschel C.M. Alnaief M. Smirnova I. Sakran A.M. Leopold C.S. Development of liquisolid compacts with improved dissolution properties for the poorly water-soluble drug valsartan. Drug Dev. Ind. Pharm. 2012 38 10 1210 1217 10.3109/03639045.2011.651836
    [Google Scholar]
  77. Dake G. Dake J. Sayyad F. Formulation and evaluation of liquisolid tablets of poorly water-soluble drug carvedilol. Int. J. Pharm. Investig. 2012 2 2 82 88 10.4103/2230‑973X.104387
    [Google Scholar]
  78. Bharadia P.D. Deshpande A.D. Chavhan S. Preparation and evaluation of liquisolid compacts of aceclofenac. Int. J. Pharm. Investig. 2013 3 1 39 45 10.4103/2230‑973X.108930
    [Google Scholar]
  79. Barghel N. Dave V. Priyanka S. Enhanced Dissolution Rate of Rosuvastatin Calcium Using Liquisolid Compact Technique. J. Adv. Pharm. Technol. Res. 2010 1 3 354 357 10.4103/0110‑5558.72423 22247871
    [Google Scholar]
  80. Dehghan M.H.G. Javadzadeh Y. Jafari-Navimipour B. Improvement of dissolution rate of indomethacin by liquisolid technique. Iran. J. Pharm. Res. 2010 9 3 243 250 24363733
    [Google Scholar]
  81. Saluja A. Yadav A.K. Sachan M. Formulation and evaluation of liquisolid compacts for improved dissolution of simvastatin. Int. J. Pharm. Investig. 2012 2 3 150 156 10.4103/2230‑973X.104406 23373006
    [Google Scholar]
  82. Karole S. Jadhav K. Kadam V. Evaluation of liquisolid technique for raloxifene hydrochloride. Res J Pharm Tech. 2009 2 2 273 276
    [Google Scholar]
  83. Patel A. Shah T. Amin A. Improvement of dissolution rate of furosemide using liquisolid compacts. J. Adv. Pharm. Technol. Res. 2011 2 2 139 145 10.4103/2231‑4040.82951 22171298
    [Google Scholar]
/content/journals/cddt/10.2174/0115701638318659240923074614
Loading
Liquisolid Technique for Solubility Enhancement of Poorly Soluble Drug - A Brief Review
Bentham Science Publishers ; https://doi.org/10.2174/0115701638318659240923074614
/content/journals/cddt/10.2174/0115701638318659240923074614
/content/journals/cddt/10.2174/0115701638318659240923074614
Loading

Data & Media loading...

  • Article Type: Review Article
Keywords: BCS classification ; coating materials ; dissolution enhancement ; carrier materials ; Liquisolid technique ; poorly water-soluble drug

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test